Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification

BACKGROUND: Enoyl-CoA hydratase domain containing 3 (ECHDC3) increased in CD34(+) progenitor cells of acute myeloid leukemia (AML) cells after chemotherapy. However, the prognostic significance and function of ECHDC3 in AML remain to be clarified. METHODS: In the training cohort, 24 AML (non-acute p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yijing, Niu, Li-Ting, Hu, Li-Juan, Lv, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511173/
https://www.ncbi.nlm.nih.gov/pubmed/36172164
http://dx.doi.org/10.3389/fonc.2022.947492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511173/
https://www.ncbi.nlm.nih.gov/pubmed/36172164
http://dx.doi.org/10.3389/fonc.2022.947492

Ejemplares similares